•
Mar 31, 2022

The Joint Q1 2022 Earnings Report

The Joint Corp. reported first quarter 2022 financial results.

Key Takeaways

The Joint Corp. reported a revenue of $22.4 million, a net loss of $206,000, or $0.01 per share, and an adjusted EBITDA of $1.8 million. The company opened 31 clinics, including 27 franchised, and achieved a milestone of 100 corporate portfolio clinics, bringing total clinics to 736.

Revenue grew 28% compared to Q1 2021.

System-wide sales increased 27% compared to Q1 2021.

System-wide comp sales grew 15% compared to Q1 2021.

Opened 31 clinics, including 27 franchised - the most for a first quarter in the company’s history.

Total Revenue
$22.4M
Previous year: $17.5M
+27.9%
EPS
-$0.01
Previous year: $0.16
-106.3%
Cash and Equivalents
$18.3M
Previous year: $17.8M
+2.8%

The Joint

The Joint

Forward Guidance

Management updated its revenue and Adjusted EBITDA guidance to reflect the impact of the macro-economic environment and the impact of increased expenses. Management reaffirmed its guidance for franchised clinic openings and company-owned or managed clinic increases.